How the Met is handling dilemma of donor accountability

Pressure is increasingly being applied to institutions benefiting from philanthropy to be accountable for their funding sources. Lately, the opioid epidemic has highlighted that dilemma: New York's famed Metropolitan Museum of Art is the latest museum to turn down money from a family linked with the manufacturing of OxyContin. Jeffrey Brown talks to the Met's president and CEO, Daniel Weiss.